Submit Deal

REVOLUTION MEDICINES INC

Summary

Revolution Medicines is a clinical-stage precision oncology company that discover and developed medicines and therapies for cancer patients.

Deals Overview

Total Deals4

Valued Deals2

Total Value£ 979 M

Avg. Deal Size£ 490 M

Market Context

Senior Management

Mark A. Goldsmith
Chairman and CEO
Jack Anders
CFO
Jeff Cislini
General Counsel

Sort

16 Oct 2018|United States|Biotechnology

Target: WARP DRIVE BIO LLC

Bidder: REVOLUTION MEDICINES INC

3 Service Providers

1 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

n/a

Value

31 Jan 2019|United States|Biotechnology

Target: GENOME MINING BUSINESS OF WARP DRIVE BIO

Bidder: GINKGO BIOWORKS INC

4 Service Providers

1 Bidder | 3 Vendor

4 Dealmakers

1 Bidder | 5 Vendor

n/a

Value

24 May 2019|United States|Biotechnology

Target: REVOLUTION MEDICINES INC

Bidder: TAVISTOCK GROUP

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 79 M

Value

01 Aug 2023|United States|Pharmaceuticals

Target: EQRX

Bidder: REVOLUTION MEDICINES INC

11 Service Providers

7 Target | 4 Bidder

109 Dealmakers

72 Target | 37 Bidder

£ 900 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Mark A. Goldsmith
Chairman and CEO
Jack Anders
CFO
Jeff Cislini
General Counsel